Cargando…
PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044047/ http://dx.doi.org/10.1186/1546-0096-11-S2-P316 |
| _version_ | 1782319069994680320 |
|---|---|
| author | Wikén, M Gozzi, P Andersson, G Olivecrona, H Aldén Raboisson, M Kullenberg, T Leinonen, M Hallén, B |
| author_facet | Wikén, M Gozzi, P Andersson, G Olivecrona, H Aldén Raboisson, M Kullenberg, T Leinonen, M Hallén, B |
| author_sort | Wikén, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4044047 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40440472014-06-17 PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS Wikén, M Gozzi, P Andersson, G Olivecrona, H Aldén Raboisson, M Kullenberg, T Leinonen, M Hallén, B Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044047/ http://dx.doi.org/10.1186/1546-0096-11-S2-P316 Text en Copyright © 2013 Wikén et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Wikén, M Gozzi, P Andersson, G Olivecrona, H Aldén Raboisson, M Kullenberg, T Leinonen, M Hallén, B PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title | PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title_full | PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title_fullStr | PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title_full_unstemmed | PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title_short | PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS |
| title_sort | pres-final-2326: no correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of anakinra (kineret(®)) in patients with severe caps |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044047/ http://dx.doi.org/10.1186/1546-0096-11-S2-P316 |
| work_keys_str_mv | AT wikenm presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT gozzip presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT anderssong presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT olivecronah presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT aldenraboissonm presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT kullenbergt presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT leinonenm presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps AT hallenb presfinal2326nocorrelationbetweenantidrugantibodiesandpharmacokineticsefficacyorsafetyofanakinrakineretinpatientswithseverecaps |